Literature DB >> 4632471

Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method.

C E Frasch, S S Chapman.   

Abstract

Neisseria meningitidis group B was subdivided into a number of different serotypes. A sensitive microbactericidal assay procedure was developed, and, with this method, over 10 different serotypes were provisionally established. The method by which distinct serotype designations were assigned is described. Almost half of the strains examined thus far contained a common serotype antigen which was distinct from the grouping antigen. Differentiation of group B meningococci into distinct types will aid in epidemiological studies and in the selection of appropriate strains for vaccines against group B meningococci.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4632471      PMCID: PMC422327          DOI: 10.1128/iai.5.1.98-102.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Serological typing of meningococci by means of micro-precipitation.

Authors:  K W SLATERUS
Journal:  Antonie Van Leeuwenhoek       Date:  1961       Impact factor: 2.271

2.  New Classification of Neisseria meningitidis by Means of Bactericidal Reactions.

Authors:  R Gold; F A Wyle
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

3.  The meningococcidal power of heparinized blood for group B organisms.

Authors:  A W Frisch
Journal:  Am J Clin Pathol       Date:  1968-08       Impact factor: 2.493

4.  Re-examination of the Neisser-Wechsberg (antibody prozone) phenomenon.

Authors:  L H Muschel; L Gustafson; L J Larsen
Journal:  Immunology       Date:  1969-10       Impact factor: 7.397

5.  Carbohydrate-containing group-specific antigens of Neisseria meningitidis.

Authors:  R I Lytle; E A Edwards; A Waggoner
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

6.  The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

7.  Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide.

Authors:  T Y Liu; E C Gotschlich; F T Dunne; E K Jonssen
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

8.  The interaction in vitro between group B meningococci and rabbit polymorphonuclear leukocytes. Demonstration of type specific opsonins and bactericidins.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1967-11-01       Impact factor: 14.307

9.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  71 in total

1.  Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis.

Authors:  K T Mountzouros; A P Howell
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

Authors:  E Holten
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

3.  Rapid serotyping of groups A, B, and C meningococci by rocket-line immunoelectrophoresis and co-agglutination.

Authors:  D Danielsson; P Olcén
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

4.  DNA Sequence analysis of the PorB protein of nonserotypeable serogroup C ET-15 meningococci suggests a potential mutational hot spot on their serotype antigens.

Authors:  Dennis K S Law; Averil M Henderson; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

5.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Interactions between the lipoprotein PilP and the secretin PilQ in Neisseria meningitidis.

Authors:  Seetha V Balasingham; Richard F Collins; Reza Assalkhou; Håvard Homberset; Stephan A Frye; Jeremy P Derrick; Tone Tønjum
Journal:  J Bacteriol       Date:  2007-05-25       Impact factor: 3.490

7.  Meningococcal infections in Scotland 1972-82.

Authors:  R J Fallon; W M Brown; W Lore
Journal:  J Hyg (Lond)       Date:  1984-10

8.  Serotypes of group B meningococci.

Authors:  D M Jones; B M Tobin
Journal:  J Clin Pathol       Date:  1976-08       Impact factor: 3.411

9.  Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model.

Authors:  L Y Wang; C E Frasch
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Identification of neisserial DNA binding components.

Authors:  Emma Lång; Kristine Haugen; Burkhard Fleckenstein; Håvard Homberset; Stephan A Frye; Ole Herman Ambur; Tone Tønjum
Journal:  Microbiology (Reading)       Date:  2009-03       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.